Action of neostigmine, DFP and CT 3318 on the sensitivity of the frog rectus abdominis muscle to the acetic, propionic and butyric esters of choline

Abstract

The potentiating effects of Neostigmine, D.F.P. and 3318 CT (a selective “true” cholinesterase inhibitor) on acetylcholine (ACh), propionylcholine (PrCh), butyrylcholine (BuCh) and amyltrimethylammonium (AmT), have been studied using the frog's rectus abdominis. Neostigmine increases the actions of the three esters much more than that of AmT. Low concentrations of D.F.P. potentiate maximally BuCh but have practically no effect on ACh, PrCh, and AmT. 3318 CT potentiates AcCh and PrCh but inhibits BuCh and AmT. These results indicate the specificity of the hydrolysis of pharmacologically active doses of BuCh, on the one hand, of AcCh and PrCh, on the other hand, by different enzymes or the frog's rectus. Results obtained with high concentrations of D.F.P. and with association of the different anticholinesterases indicate that a maximal or nearly maximal potentiation of one of these esters is already obtained with the specific inhibitor concerned; the supplementary inhibition of the non-specific enzymes thus appears to have no or only a poor effect.